Akebia Therapeutics





Ebit Değişiklik Tarih
Acadia Pharmaceuticals USD 35.76M 3.38M 2025-09
Agios Pharmaceuticals USD -116.87M 10.19M 2025-09
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Amgen USD 3.96B 464M 2025-12
Ardelyx USD 7.12M 19.62M 2025-09
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR -399M 363M 2025-09
BioMarin Pharmaceutical USD -31.69M 308.58M 2025-09
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 1.22B 60.54M 2025-09
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Exelixis USD 235.91M 20.45M 2025-12
Fresenius Medical Care EUR 449.94M 18.94M 2025-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 5.11B 2.3B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Knight Therapeutics CAD 3.2M 1.29M 2024-09
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Lexicon Pharmaceuticals USD -49.63M 5.39M 2023-09
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -12.12M 3.97M 2023-06
Moderna USD -260M 557M 2025-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Organigram Holdings CAD -28.05M 25.94M 2025-09
Pharma Mar EUR -3.96M 28.11M 2025-09
Prothena USD -39.76M 12.25M 2025-09
PTC Therapeutics USD 3.49M 38.35M 2025-09
Qiagen NV USD 121.88M 19.18M 2025-12
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sanofi EUR 1.7B 2.17B 2025-12
Sarepta Therapeutics USD -62.88M 178.46M 2025-09
Sartorius EUR 150.1M 11.7M 2025-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Tilray USD -20.01M 9.34M 2025-09
Vanda Pharmaceuticals USD -10.28M 721K 2024-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09


Akebia Therapeutics - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Feb 2026.